Skip to Main Content

Paper Details

FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience.
JCO Precis Oncol
5
2021
AST, CCA, Cholangiocarcinoma, Cholangiocarcinomas, FGFR, FGFR alterations, FGFRi, anemia, cancer, fatigue, fibroblast growth factor receptor, hyperphosphatemia, intrahepatic CCAs, patients, platelet, tumors

Datasets

Release 1.2